Can-Fite BioPharma Ltd.
- Last sale
- Nov 12, 2026 · -7.01%
- Market cap
- $1.91M
- 1.31M shares
- Filings
- 868
FY 2025−39.9% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+14.6% FY25 yoy
- $1.91M
- —
- 4.7×
- 0.3×
- -468.28%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $405,000 | reported | |
| FY 2024 | 2024-12-31 | $674,000 | reported | |
| FY 2023 | 2023-12-31 | $743,000 | reported | |
| FY 2022 | 2022-12-31 | $810,000 | reported | |
| FY 2021 | 2021-12-31 | $853,000 | reported | |
| FY 2020 | 2020-12-31 | $763,000 | reported | |
| FY 2019 | 2019-12-31 | $2,032,000 | reported | |
| FY 2018 | 2018-12-31 | $3,820,000 | reported | |
| FY 2017 | 2017-12-31 | $789,000 revised | reported | |
| FY 2016 | 2016-12-31 | $165,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2021 | $2.59M | — | $2.59M | — | 815.75M sh | +75.9% | — |
| FY2020 | $715.00K | — | $715.00K | — | 463.77M sh | +284.4% | — |
Pharmaceutical preparations
Can-Fite BioPharma Ltd. is the 231st largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
QUCYQuantum Cyber N.V.$537.1K39.9%3,018.3%$49.2MMREOMereo BioPharma Group plc$500.0K—8,375.6%$243.3MSCNXScienture Holdings, Inc.$431.6K215.9%9,618.0%$5.2MMNOVMedicinova Inc$409.7K—2,928.8%$72.0M
CANFCan-Fite BioPharma Ltd. (this company)$405.0K39.9%2,426.7%$1.9M
PVCTProvectus Biopharmaceuticals, Inc.$336.1K45.5%1,615.8%$29.2MALLRAllarity Therapeutics, Inc.$320.0K—3,509.7%$14.7MHINDVyome Holdings, Inc$319.7K96.0%3,209.7%$11.1MABVCAbvc Biopharma, Inc.$296.0K41.9%2,671.8%$26.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Can-Fite BioPharma Ltd. · CIK 1536196 · Engraved from SEC EDGAR